Prince Akwasi Mensah

Array ( [id] => 737744 [patent_doc_number] => 07034054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols' [patent_app_type] => utility [patent_app_number] => 10/020450 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19459 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034054.pdf [firstpage_image] =>[orig_patent_app_number] => 10020450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845459 [patent_doc_number] => 20020132845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Compositions and methods for the prevention and treatment of tissue ischemia' [patent_app_type] => new [patent_app_number] => 10/017717 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33984 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132845.pdf [firstpage_image] =>[orig_patent_app_number] => 10017717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570570 [patent_doc_number] => 06498173 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Synergistic combination comprising roflumilast and a pde-3 inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/959599 [patent_app_country] => US [patent_app_date] => 2001-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498173.pdf [firstpage_image] =>[orig_patent_app_number] => 09959599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159094 [patent_doc_number] => 20020147211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Intraocular tension lowering compositions for topical administration' [patent_app_type] => new [patent_app_number] => 10/016535 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5088 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147211.pdf [firstpage_image] =>[orig_patent_app_number] => 10016535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779168 [patent_doc_number] => 20030050250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Alpha v beta 3 integrin antagonists in combination with chemotherapeutic agents' [patent_app_type] => new [patent_app_number] => 10/016146 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21975 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050250.pdf [firstpage_image] =>[orig_patent_app_number] => 10016146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005505 [patent_doc_number] => 06906102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Use of isovaleryl L-carnitine to increase healing of bone fractures' [patent_app_type] => utility [patent_app_number] => 10/470158 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1891 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906102.pdf [firstpage_image] =>[orig_patent_app_number] => 10470158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535043 [patent_doc_number] => 06489340 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Macrolide compounds for inducing chondrogenic differentiation' [patent_app_type] => B1 [patent_app_number] => 09/926700 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3176 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 474 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489340.pdf [firstpage_image] =>[orig_patent_app_number] => 09926700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017020 [patent_doc_number] => 20020103199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Fused heteroaromatic glucokinase activators' [patent_app_type] => new [patent_app_number] => 10/006170 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23973 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103199.pdf [firstpage_image] =>[orig_patent_app_number] => 10006170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016961 [patent_doc_number] => 20020103174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Use of eugenol, alone, and in combination with other chemopreventative agents as prophylaxis for cancers' [patent_app_type] => new [patent_app_number] => 10/004105 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2550 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103174.pdf [firstpage_image] =>[orig_patent_app_number] => 10004105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1603009 [patent_doc_number] => 06433188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Fused heteroaromatic glucokinase activators' [patent_app_type] => B1 [patent_app_number] => 10/006005 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23737 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/433/06433188.pdf [firstpage_image] =>[orig_patent_app_number] => 10006005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082365 [patent_doc_number] => 20020082222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Treatments for neurogenetic disorders, impulse control disorder, and wound healing' [patent_app_type] => new [patent_app_number] => 09/997447 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10364 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082222.pdf [firstpage_image] =>[orig_patent_app_number] => 09997447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637134 [patent_doc_number] => 20020086867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria' [patent_app_type] => new [patent_app_number] => 09/996040 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4989 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086867.pdf [firstpage_image] =>[orig_patent_app_number] => 09996040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080810 [patent_doc_number] => 06835753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Fc receptor modulators and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/995277 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17736 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835753.pdf [firstpage_image] =>[orig_patent_app_number] => 09995277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178141 [patent_doc_number] => 20020156112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Endostatin-like angiogenesis inhibition' [patent_app_type] => new [patent_app_number] => 10/003681 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8310 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156112.pdf [firstpage_image] =>[orig_patent_app_number] => 10003681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923350 [patent_doc_number] => 20020115683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Treatment of anti-depression drug-induced sexual dysfunction with apomorphine' [patent_app_type] => new [patent_app_number] => 09/993782 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3669 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115683.pdf [firstpage_image] =>[orig_patent_app_number] => 09993782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048730 [patent_doc_number] => 20020169187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Method of treating Parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/054758 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4604 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169187.pdf [firstpage_image] =>[orig_patent_app_number] => 10054758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216750 [patent_doc_number] => 06706704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Method of inducing opioid analgesia and anesthesia without respiratory suppression' [patent_app_type] => B2 [patent_app_number] => 10/007596 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 45 [patent_no_of_words] => 11200 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706704.pdf [firstpage_image] =>[orig_patent_app_number] => 10007596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369750 [patent_doc_number] => 06566387 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'IL-8 receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 10/009212 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10213 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566387.pdf [firstpage_image] =>[orig_patent_app_number] => 10009212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969128 [patent_doc_number] => 20020091140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Method of treating and preventing migraine headaches' [patent_app_type] => new [patent_app_number] => 09/999251 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091140.pdf [firstpage_image] =>[orig_patent_app_number] => 09999251 [rel_patent_id] =>[rel_patent_doc_number] =>)